Sage Therapeutics Appoints Michael Quirk, Ph.D. as Chief Medical Officer After Laura Gault Steps Down
Position
Chief Medical Officer
Company
SAGE Therapeutics
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsDescription
Sage Chief Medical Officer Laura Gault, M.D., Ph.D., is stepping down effective March 21, after a recent string of clinical failures. In the interim, Chief Scientific Officer Michael Quirk, Ph.D., will fill the CMO role.
Quick answer
Sage Therapeutics Appoints Michael Quirk, Ph.D. as Chief Medical Officer After Laura Gault Steps Down (March 7, 2025). SAGE Therapeutics is based in Cambridge, Massachusetts, United States.
- What did SAGE Therapeutics announce on March 7, 2025?
- Sage Chief Medical Officer Laura Gault, M.D., Ph.D., is stepping down effective March 21, after a recent string of clinical failures. In the interim, Chief Scientific Officer Michael Quirk, Ph.D., will fill the CMO role.
- What does SAGE Therapeutics do?
- SAGE Therapeutics, Inc. is a biotechnology company dedicated to developing therapies for central nervous system disorders.
- Where is SAGE Therapeutics based?
- SAGE Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Crinetics Pharmaceuticals (February 26, 2025), Immuneering (March 20, 2025), Verrica (March 26, 2025) and Geneoscopy (April 2, 2025) also announced leadership changes within 45 days of SAGE Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Igor Matushansky, MD, PhD, Joins Immuneering as Chief Medical Officer (March 20, 2025)
- Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer (March 26, 2025)
- Geneoscopy Appoints Amit Bhalla as Chief Financial Officer (April 2, 2025)
- TuHURA Appoints Bertrand Le Bourdonnec as Executive Vice President (April 7, 2025)
- Inhibikase Therapeutics Appoints David McIntyre as Chief Financial Officer (April 14, 2025)
Who to call at SAGE Therapeutics, and when
A new leader at SAGE Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day SAGE Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SAGE Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SAGE Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SAGE Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SAGE Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.